Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
| Status: | Completed |
|---|---|
| Conditions: | Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Colorectal Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Smoking Cessation, Lymphoma, Tobacco Consumers, Bladder Cancer |
| Therapuetic Areas: | Oncology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 19 - 120 |
| Updated: | 4/21/2016 |
| Start Date: | June 1992 |
Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings
RATIONALE: Physician-initiated smoking cessation strategies may be effective in getting
early-stage cancer patients to quit smoking.
PURPOSE: Randomized clinical trial to compare the effectiveness of a physician-initiated
stop-smoking program with the usual care for patients receiving treatment for early-stage
cancer.
early-stage cancer patients to quit smoking.
PURPOSE: Randomized clinical trial to compare the effectiveness of a physician-initiated
stop-smoking program with the usual care for patients receiving treatment for early-stage
cancer.
OBJECTIVES:
- Compare the efficacy of brief physician-initiated smoking cessation strategies vs usual
care in patients with early stage cancer who are undergoing treatment in clinical
oncology settings.
- Compare the sociodemographic, smoking history, and health status correlates of smoking
cessation in patients treated with these regimens.
- Determine the feasibility of conducting a cancer prevention and control study in a
cooperative group setting by monitoring adherence to the smoking-cessation strategies.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to
center. Patients are randomized to 1 of 2 treatment arms.
- Arm I: Patients receive usual care (no special intervention).
- Arm II: Patients receive smoking-cessation therapy based on the 4-step intervention
plan in the "Manual for Physicians" published by the National Cancer Institute. The
smoking cessation coordinator and physician provide self-quitting advice and support to
the patient via counseling, self-help materials, and referral to a smoking cessation
counselor at the Cancer Information Service (CIS). Patients receive nicotine
replacement, if indicated. Patients who express an interest in more intensive treatment
are referred to local American Cancer Society or American Lung Association clinics
and/or advised to call the CIS for additional local program referrals.
All patients are followed at 6 and 12 months. Patients who report that they are still
smoking and interested in help to quit smoking at the 12-month follow-up interview are
encouraged to return to their physicians and contact the CIS for additional help quitting or
for a referral to more intensive or specialized treatments in their area.
PROJECTED ACCRUAL: A total of 494 patients will be accrued for this study.
- Compare the efficacy of brief physician-initiated smoking cessation strategies vs usual
care in patients with early stage cancer who are undergoing treatment in clinical
oncology settings.
- Compare the sociodemographic, smoking history, and health status correlates of smoking
cessation in patients treated with these regimens.
- Determine the feasibility of conducting a cancer prevention and control study in a
cooperative group setting by monitoring adherence to the smoking-cessation strategies.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to
center. Patients are randomized to 1 of 2 treatment arms.
- Arm I: Patients receive usual care (no special intervention).
- Arm II: Patients receive smoking-cessation therapy based on the 4-step intervention
plan in the "Manual for Physicians" published by the National Cancer Institute. The
smoking cessation coordinator and physician provide self-quitting advice and support to
the patient via counseling, self-help materials, and referral to a smoking cessation
counselor at the Cancer Information Service (CIS). Patients receive nicotine
replacement, if indicated. Patients who express an interest in more intensive treatment
are referred to local American Cancer Society or American Lung Association clinics
and/or advised to call the CIS for additional local program referrals.
All patients are followed at 6 and 12 months. Patients who report that they are still
smoking and interested in help to quit smoking at the 12-month follow-up interview are
encouraged to return to their physicians and contact the CIS for additional help quitting or
for a referral to more intensive or specialized treatments in their area.
PROJECTED ACCRUAL: A total of 494 patients will be accrued for this study.
DISEASE CHARACTERISTICS:
- One of the following diagnoses:
- Stage I or II bladder, colorectal, head and neck, lung, or other cancer
- Stage I-III testicular cancer
- Stage I-IV breast cancer, prostate cancer, or lymphoma
- Must have smoked 1 or more cigarettes within the past month or define self as a
smoker
- Hormone receptor status:
- Not specified
PATIENT CHARACTERISTICS:
Age:
- 19 and over
Sex:
- Not specified
Menopausal status:
- Not specified
Performance status:
- ECOG 0-1
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Not specified
Cardiovascular:
- No history of recent heart attack
Other:
- Not pregnant
- No other imminent medical needs requiring referral to a more intensive smoking
cessation regimen
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- Not specified
Chemotherapy:
- Not specified
Endocrine therapy:
- Not specified
Radiotherapy:
- Not specified
Surgery:
- Not specified
Other:
- No prior participation in the pilot phase study
We found this trial at
1
site
Click here to add this to my saved trials
